AROCELL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4 SEK | -6.10% |
|
0.00% | -8.47% |
| May. 03 | AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 8.66M | - | |||||
| 44.44B | - | |||||
| 37.99B | ||||||
| 37.75B | ||||||
| 30.78B | - | |||||
| 27.38B |
- Stock Market
- Equities
- AROC Stock
- Charts AroCell AB
- Sector Chart
